Cytek Biosciences (CTKB) Intangibles (2020 - 2026)

Cytek Biosciences has reported Intangibles for 7 years, with the latest figure at $15.7 million in Q1 2026.

• For the quarter ending Q1 2026, Intangibles fell 19.18% year-over-year to $15.7 million; the trailing twelve-month figure through Mar 2026 stood at $15.7 million (down 19.18% YoY), and the FY2025 full-year result was $16.8 million, down 16.43% from the prior year.
• Intangibles for Q1 2026 stood at $15.7 million, down from $16.8 million in the prior quarter.
• The five-year high for Intangibles was $24.7 million in Q1 2023, with the low at $3.9 million in Q2 2022.
• Historically, Intangibles has averaged $16.8 million across 5 years, with a median of $19.4 million in 2025.
• Annual changes were most pronounced in 2022 — Intangibles jumped 1142.38% — and 2026, when it decreased 19.18%.
• Cytek Biosciences' Intangibles stood at $4.3 million in 2022, then surged by 432.99% to $23.1 million in 2023, then retreated by 12.81% to $20.1 million in 2024, then retreated by 16.43% to $16.8 million in 2025, then decreased by 6.64% to $15.7 million in 2026.
• The last three Intangibles figures came in at $15.7 million (Q1 2026), $16.8 million (Q4 2025), and $17.7 million (Q3 2025), per Business Quant data.